Abiopharma

News list

VERNON W ANTHONY 🟡 adjusted position in 0 shares (1 derivative) of NovoCure Ltd (NVCR) at $11.39 Transaction Date: Apr 28, 2026 | Filing ID: 000002

Full text

News bot April 28, 2026, 8:28 p.m.
🔍 VERNON W ANTHONY (Executive)

Company: NovoCure Ltd (NVCR)

Report Date: 2026-04-28
Transaction Summary:
- Total transactions: 2
- Derivative instruments: 1
- Holdings reported: 0
- Total shares acquired: 21,500
- Total shares sold: 21,500
Detailed Transactions and Holdings:
- Acquired 21,500 shares of Ordinary Shares at $11.39 per share (Direct)
  Date: 2026-04-28 | Code: M | equity_swap_involved: false | shares_owned_after: 200,602.00 | transaction_form_type: 4
- Sold 21,500 shares of Stock Option (Right to Buy) at $11.39 per share (Derivative)
  Date: 2026-04-28 | Code: M | Expires: 2026-05-04 | Exercise: 2017-05-04 | equity_swap_involved: false | transaction_form_type: 4